Venus Medtech (Hangzhou) Inc. announced unaudited consolidated earnings results for the six months ended June 30, 2021. For the period, the company reported revenue was RMB 239,269,000 against RMB 102,049,000 a year ago. Loss before tax was RMB 117,211,000 against RMB 43,529,000 a year ago. Loss for the period was RMB 117,215,000 against RMB 43,538,000 a year ago. Basic and diluted was RMB 0.26 against RMB 0.11 a year ago.